{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:57:24Z","timestamp":1783036644800,"version":"3.54.6"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Psoriasis is a skin condition associated with increased risks of developing metabolic diseases, such as diabetes and hyperlipidaemia. Retinoid drugs, including acitretin, are commonly used to treat psoriasis due to its low cost and tolerable side effects.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> This study aimed to explore the influence of acitretin on patients' metabolism levels, especially lipid and glucose.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this retrospective study, a total of 685 psoriatic patients and 395 age\/sex matched controls were enrolled. The demographic and biochemical indexes of each participant were recorded. Acitretin (30 mg\/d) combined with the topical ointment calcipotriol was used to treat the psoriatic patients, and the glucose and lipid profiles of patients before and after acitretin treatment were analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The blood glucose levels of 685 psoriasis patients were significantly higher than that of the control group (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), while the blood lipid levels showed no difference between psoriatic patients and the matched controls. Triglyceride and low-density lipoprotein levels were significantly increased in 247 patients (<jats:italic>P<\/jats:italic> &amp;lt; 0.05) after 8 weeks of treatment with acitretin. Interestingly, there was a remarkable downward trend in body mass index (BMI) and blood glucose levels (<jats:italic>P<\/jats:italic> &amp;lt; 0.05) after acitretin treatment. Additionally, expression of both <jats:italic>GLUT1<\/jats:italic> and <jats:italic>GLUT4<\/jats:italic> in HaCaT and HepG2 cells were significantly increased when treated with acitretin. Compared to acitretin-free cells, the uptake of 2-NBDG was significantly higher in HaCaT and HepG2 cells after incubation with 5000 ng\/mL acitretin for 36 h.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Acitretin plays a significant role of reducing the blood glucose level in psoriasis patients. The mechanism of lowering blood glucose may be through increasing glucose intake by cells, thereby reducing glucose levels in the peripheral blood.<\/jats:p>","DOI":"10.3389\/fmed.2021.764216","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T12:07:48Z","timestamp":1639656468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Reductive Effect of Acitretin on Blood Glucose Levels in Chinese Patients With Psoriasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Hua","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jamadermatol.2014.3593","article-title":"Dhillon JS, Armstrong AW","volume":"151","author":"Brezinski","year":"2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Sch\u00f6n MP. Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2011.06.035","article-title":"Langley RG, You Y, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","article-title":"Psoriasis and mortality in the US: data from the National Health and Nutrition Examination Survey","volume":"85","author":"Semenov","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/CCID.S44843","article-title":"Psoriasis and comorbidities: links and risks","volume":"7","author":"Ni","year":"2014","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B6","volume-title":"J. Am. Acad. Dermatol","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study","volume":"33","author":"Fern\u00e1ndez-Armenteros","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","article-title":"Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology","volume":"162","author":"Ormerod","year":"2010","journal-title":"Br J Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1684\/ejd.2015.2544","article-title":"Retinoid treatment of skin diseases","volume":"25","author":"Beckenbach","year":"2015","journal-title":"Eur J Dermatol"},{"key":"B10","first-page":"458","article-title":"Cole CA. Vitamin A and its derivatives in experimental photocarcinogenesis: preventive effects and relevance to humans","volume":"12","author":"Shapiro","year":"2013","journal-title":"J Drugs Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jsps.2017.04.034","article-title":"Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling","volume":"25","author":"Qin","year":"2017","journal-title":"Saudi Pharm J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1523-1747.1998.00393.x","article-title":"Retinoids downregulate vascular endothelial growth factor\/vascular permeability factor production by normal human keratinocytes","volume":"111","author":"Weninger","year":"1998","journal-title":"J Invest Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1346-8138.2012.01637.x","article-title":"Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris","volume":"39","author":"Niu","year":"2012","journal-title":"J. Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/17425255.2018.1515198","article-title":"Sahni DR, Curry ZA, Feldman SR. Pharmacokinetics of tazarotene and acitretin in psoriasis","volume":"14","author":"Heath","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/ijd.14349","article-title":"Long-term safety drug survival of acitretin in psoriasis: a retrospective observational study","volume":"58","author":"Chularojanamontri","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"B16","first-page":"249","volume-title":"Retinoid-Induced Hyperlipidemia and the Risk of Atherosclerosis","author":"Vahlquist","year":"2007"},{"key":"B17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cvr\/cvq360","article-title":"A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling","volume":"89","author":"Kennedy","year":"2011","journal-title":"Cardiovasc Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3945\/jn.109.115147","article-title":"Bhat PV. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice","volume":"140","author":"Manolescu","year":"2010","journal-title":"J Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nutres.2015.11.018","article-title":"High dietary fat-induced obesity in Wistar rats and type 2 diabetes in nonobese Goto-Kakizaki rats differentially affect retinol binding protein 4 expression and vitamin A metabolism","volume":"36","author":"Shirai","year":"2016","journal-title":"Nutr Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2337\/db17-0946","article-title":"Smullin CP, Kim M, Lo CP, Devericks E, et al. Modest Decreases in Endogenous All\u2013Retinoic Acid Produced by a Mouse Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism","volume":"67","author":"Yang","year":"2018","journal-title":"Diabetes."},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/eje.1.02057","article-title":"Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines","volume":"154","author":"Corbetta","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.febslet.2014.02.029","article-title":"Identification of insulin as a novel retinoic acid receptor-related orphan receptor \u03b1 target gene","volume":"588","author":"Kuang","year":"2014","journal-title":"FEBS Lett"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-18-3842","article-title":"Retinoic acid-related orphan receptor c regulates proliferation, glycolysis, and chemoresistance via the PD-L1\/ITGB6\/STAT3 signaling axis in bladder cancer","volume":"79","author":"Cao","year":"2019","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1004331","DOI":"10.1371\/journal.pgen.1004331","article-title":"Retinoic acid-related orphan receptor gamma (RORgamma): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity","volume":"10","author":"Takeda","year":"2014","journal-title":"PLoS Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1096\/fj.14-256743","article-title":"Yuen JJ, Das BC, et al. Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and beta-cell mass","volume":"29","author":"Brun","year":"2015","journal-title":"FASEB J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4093\/dmj.2012.36.3.167","article-title":"Retinoid metabolism and diabetes mellitus","volume":"36","author":"Rhee","year":"2012","journal-title":"Diabetes Metab J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1021\/acs.jproteome.8b00917","volume":"18","year":"2019","journal-title":"J. Proteome Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1139\/o11-079","article-title":"Roles of vitamin A status and retinoids in glucose and fatty acid metabolism","volume":"90","author":"Zhao","year":"2012","journal-title":"Biochem Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1463-1326.2011.01407.x","article-title":"Giridharan NV, Vajreswari A. Vitamin A improves insulin sensitivity by increasing insulin receptor phosphorylation through protein tyrosine phosphatase 1B regulation at early age in obese rats of WNIN\/Ob strain","volume":"13","author":"Jeyakumar","year":"2011","journal-title":"Diabetes Obes Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1096\/fj.15-281543","article-title":"Retinol as a cofactor for PKCdelta-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity","volume":"30","author":"Shabrova","year":"2016","journal-title":"FASEB J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"33969","DOI":"10.1074\/jbc.M804469200","article-title":"Lee JO, Jung JH, Kim JH, Park SH, Park JM, et al. Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/1096620041938696","article-title":"Ahn IS, Jung HS, Rayner DV, Do MS. Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro","volume":"7","author":"Hong","year":"2004","journal-title":"J Med Food."},{"key":"B33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41467-017-00215-1","article-title":"ROR\u03b1 controls hepatic lipid homeostasis via negative regulation of PPAR\u03b3 transcriptional network","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00395-005-0567-y","article-title":"Retinoic acids increase expression of GLUT4 in dedifferentiated and hypertrophied cardiac myocytes","volume":"101","author":"Montessuit","year":"2006","journal-title":"Basic Res Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41591-018-0003-0","article-title":"Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/exd.13850","article-title":"Membrane-enriched solute carrier family 2 member 1 (SLC2A1\/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment","volume":"28","author":"Huang","year":"2019","journal-title":"Exp Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis psoriatic arthritis: section 4 Guidelines of care for the management treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/1346-8138.13713","article-title":"Efficacy, safety drug survival of conventional agents in pediatric psoriasis: a multicenter, cohort study","volume":"44","author":"Ergun","year":"2017","journal-title":"J Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.764216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T12:07:52Z","timestamp":1639656472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.764216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":38,"alternative-id":["10.3389\/fmed.2021.764216"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.764216","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"764216"}}